MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹306 Cr | ₹207 Cr | ₹493 Cr | ₹670 Cr | ₹372 Cr |
What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹306 Cr |
| Mar2024 | ₹207 Cr |
| Mar2023 | ₹493 Cr |
| Mar2022 | ₹670 Cr |
| Mar2021 | ₹372 Cr |
How is Capital Work in Progress of MANKIND PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹306 Cr | 47.82 | |
| Mar2024 | ₹207 Cr | -58.01 | |
| Mar2023 | ₹493 Cr | -26.38 | |
| Mar2022 | ₹670 Cr | 80.26 | |
| Mar2021 | ₹372 Cr | - | |
Compare Capital Work in Progress of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹88,995.6 Cr | 2.6% | -2.1% | -16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.6% |
-2.1% |
-16.6% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses